B. Kandel (ed.)
Stages and Pathways of Drug Involvement
Examining the Gateway Hypothesis
Herausgeber: Kandel, Denise Bystryn
B. Kandel (ed.)
Stages and Pathways of Drug Involvement
Examining the Gateway Hypothesis
Herausgeber: Kandel, Denise Bystryn
- Broschiertes Buch
- Merkliste
- Auf die Merkliste
- Bewerten Bewerten
- Teilen
- Produkt teilen
- Produkterinnerung
- Produkterinnerung
This book represents a systematic and broadly based discussion and evaluation of the Gateway Hypothesis.
Andere Kunden interessierten sich auch für
- Richard Bryant-JefferiesCounselling a Recovering Drug User52,99 €
- Nadia SolowijCannabis and Cognitive Functioning89,99 €
- Jon Elster / Ole-Jørgen Skog (eds.)Getting Hooked70,99 €
- Laird Patrick BridgmanWhere to From Here? A guide for groups working the twelve steps of RSA.14,99 €
- George R. RossTreating Adolescent Substance Abuse: Understanding the Fundamental Elements33,99 €
- Joseph WoodardReaching America's Runaways12,99 €
- Matthew EdwardsWhat I Couldn't Tell You28,99 €
-
-
-
This book represents a systematic and broadly based discussion and evaluation of the Gateway Hypothesis.
Hinweis: Dieser Artikel kann nur an eine deutsche Lieferadresse ausgeliefert werden.
Hinweis: Dieser Artikel kann nur an eine deutsche Lieferadresse ausgeliefert werden.
Produktdetails
- Produktdetails
- Verlag: Cambridge University Press
- Seitenzahl: 402
- Erscheinungstermin: 3. September 2013
- Englisch
- Abmessung: 229mm x 152mm x 24mm
- Gewicht: 650g
- ISBN-13: 9780521789691
- ISBN-10: 0521789699
- Artikelnr.: 22391179
- Herstellerkennzeichnung
- Books on Demand GmbH
- In de Tarpen 42
- 22848 Norderstedt
- info@bod.de
- 040 53433511
- Verlag: Cambridge University Press
- Seitenzahl: 402
- Erscheinungstermin: 3. September 2013
- Englisch
- Abmessung: 229mm x 152mm x 24mm
- Gewicht: 650g
- ISBN-13: 9780521789691
- ISBN-10: 0521789699
- Artikelnr.: 22391179
- Herstellerkennzeichnung
- Books on Demand GmbH
- In de Tarpen 42
- 22848 Norderstedt
- info@bod.de
- 040 53433511
Part I. Overview: 1. Examining the gateway hypothesis: stages and pathways
of drug involvement Denise B. Kandel; Part II. Recent Substantive Findings:
What Do We Know about Stages of Drug Use, Risks and Protective Factors?: 2.
Drug sequences, age of onset and use trajectories as predictors of drug
abuse/dependence in young adulthood Erich Labouvie and Helene R. White; 3.
Substance use norms and transitions in substance use: implications for the
gateway hypothesis David Hawkins, Karl G. Hill, Jie Guo and Sara R.
Battin-Pearson; 4. Stages of drug involvement in the US population Denise
B. Kandel and Kazuo Yamaguchi; 5. Substance use progression and hard drug
use in inner city New York Andrew Golub and Bruce D. Johnson; Part III.
Impact of Prevention Interventions: a Test of the Progression Hypothesis:
6. Preventing the onset and developmental progression of adolescent drug
use: implications for the gateway theory Gilbert Botvin, Kenneth Griffin
and Lawrence Scheier; 7. The gateway theory applied to prevention Mary Ann
Pentz and Chaoyang Li; 8. Intervention effects on adult drug use and
critical influence on development of problem behavior Anthony Biglan and
Keith Smolkowski; Part IV. Methodological Issues and Approaches: Advantages
and Limitations of Alternate Methods: 9. Log linear sequence analysis:
gender and racial/ethnic differences in drug-use progression Kazuo
Yamaguchi and Denise B. Kandel; 10. Cigarette use and drug use progression:
a growth trajectory and lagged effect hypothesis Peter M. Bentler, Michael
D. Newcomb and Marc A. Zimmerman; 11. Using latent transition analysis to
examine the gateway hypothesis Linda Collins; 12. Stages of drug
progression: a comparison of methods, concepts and operationalizations
Kazuo Yamaguchi; Part V. Animal Models and Biological Professes:
Implications for Drug Progression: 13. The value of animal models to
examine the gateway hypothesis Neil E. Grunberg and Martha M. Faraday; 14.
Sensitization as a process underlying the progression of drug use via
gateway drugs Susan Schenk; 15. The neurobiology of drug addiction George
Koob; Part VI. Conclusion: 16. The gateway hypothesis revisited Denise B.
Kandel and Richard Jessor.
of drug involvement Denise B. Kandel; Part II. Recent Substantive Findings:
What Do We Know about Stages of Drug Use, Risks and Protective Factors?: 2.
Drug sequences, age of onset and use trajectories as predictors of drug
abuse/dependence in young adulthood Erich Labouvie and Helene R. White; 3.
Substance use norms and transitions in substance use: implications for the
gateway hypothesis David Hawkins, Karl G. Hill, Jie Guo and Sara R.
Battin-Pearson; 4. Stages of drug involvement in the US population Denise
B. Kandel and Kazuo Yamaguchi; 5. Substance use progression and hard drug
use in inner city New York Andrew Golub and Bruce D. Johnson; Part III.
Impact of Prevention Interventions: a Test of the Progression Hypothesis:
6. Preventing the onset and developmental progression of adolescent drug
use: implications for the gateway theory Gilbert Botvin, Kenneth Griffin
and Lawrence Scheier; 7. The gateway theory applied to prevention Mary Ann
Pentz and Chaoyang Li; 8. Intervention effects on adult drug use and
critical influence on development of problem behavior Anthony Biglan and
Keith Smolkowski; Part IV. Methodological Issues and Approaches: Advantages
and Limitations of Alternate Methods: 9. Log linear sequence analysis:
gender and racial/ethnic differences in drug-use progression Kazuo
Yamaguchi and Denise B. Kandel; 10. Cigarette use and drug use progression:
a growth trajectory and lagged effect hypothesis Peter M. Bentler, Michael
D. Newcomb and Marc A. Zimmerman; 11. Using latent transition analysis to
examine the gateway hypothesis Linda Collins; 12. Stages of drug
progression: a comparison of methods, concepts and operationalizations
Kazuo Yamaguchi; Part V. Animal Models and Biological Professes:
Implications for Drug Progression: 13. The value of animal models to
examine the gateway hypothesis Neil E. Grunberg and Martha M. Faraday; 14.
Sensitization as a process underlying the progression of drug use via
gateway drugs Susan Schenk; 15. The neurobiology of drug addiction George
Koob; Part VI. Conclusion: 16. The gateway hypothesis revisited Denise B.
Kandel and Richard Jessor.
Part I. Overview: 1. Examining the gateway hypothesis: stages and pathways
of drug involvement Denise B. Kandel; Part II. Recent Substantive Findings:
What Do We Know about Stages of Drug Use, Risks and Protective Factors?: 2.
Drug sequences, age of onset and use trajectories as predictors of drug
abuse/dependence in young adulthood Erich Labouvie and Helene R. White; 3.
Substance use norms and transitions in substance use: implications for the
gateway hypothesis David Hawkins, Karl G. Hill, Jie Guo and Sara R.
Battin-Pearson; 4. Stages of drug involvement in the US population Denise
B. Kandel and Kazuo Yamaguchi; 5. Substance use progression and hard drug
use in inner city New York Andrew Golub and Bruce D. Johnson; Part III.
Impact of Prevention Interventions: a Test of the Progression Hypothesis:
6. Preventing the onset and developmental progression of adolescent drug
use: implications for the gateway theory Gilbert Botvin, Kenneth Griffin
and Lawrence Scheier; 7. The gateway theory applied to prevention Mary Ann
Pentz and Chaoyang Li; 8. Intervention effects on adult drug use and
critical influence on development of problem behavior Anthony Biglan and
Keith Smolkowski; Part IV. Methodological Issues and Approaches: Advantages
and Limitations of Alternate Methods: 9. Log linear sequence analysis:
gender and racial/ethnic differences in drug-use progression Kazuo
Yamaguchi and Denise B. Kandel; 10. Cigarette use and drug use progression:
a growth trajectory and lagged effect hypothesis Peter M. Bentler, Michael
D. Newcomb and Marc A. Zimmerman; 11. Using latent transition analysis to
examine the gateway hypothesis Linda Collins; 12. Stages of drug
progression: a comparison of methods, concepts and operationalizations
Kazuo Yamaguchi; Part V. Animal Models and Biological Professes:
Implications for Drug Progression: 13. The value of animal models to
examine the gateway hypothesis Neil E. Grunberg and Martha M. Faraday; 14.
Sensitization as a process underlying the progression of drug use via
gateway drugs Susan Schenk; 15. The neurobiology of drug addiction George
Koob; Part VI. Conclusion: 16. The gateway hypothesis revisited Denise B.
Kandel and Richard Jessor.
of drug involvement Denise B. Kandel; Part II. Recent Substantive Findings:
What Do We Know about Stages of Drug Use, Risks and Protective Factors?: 2.
Drug sequences, age of onset and use trajectories as predictors of drug
abuse/dependence in young adulthood Erich Labouvie and Helene R. White; 3.
Substance use norms and transitions in substance use: implications for the
gateway hypothesis David Hawkins, Karl G. Hill, Jie Guo and Sara R.
Battin-Pearson; 4. Stages of drug involvement in the US population Denise
B. Kandel and Kazuo Yamaguchi; 5. Substance use progression and hard drug
use in inner city New York Andrew Golub and Bruce D. Johnson; Part III.
Impact of Prevention Interventions: a Test of the Progression Hypothesis:
6. Preventing the onset and developmental progression of adolescent drug
use: implications for the gateway theory Gilbert Botvin, Kenneth Griffin
and Lawrence Scheier; 7. The gateway theory applied to prevention Mary Ann
Pentz and Chaoyang Li; 8. Intervention effects on adult drug use and
critical influence on development of problem behavior Anthony Biglan and
Keith Smolkowski; Part IV. Methodological Issues and Approaches: Advantages
and Limitations of Alternate Methods: 9. Log linear sequence analysis:
gender and racial/ethnic differences in drug-use progression Kazuo
Yamaguchi and Denise B. Kandel; 10. Cigarette use and drug use progression:
a growth trajectory and lagged effect hypothesis Peter M. Bentler, Michael
D. Newcomb and Marc A. Zimmerman; 11. Using latent transition analysis to
examine the gateway hypothesis Linda Collins; 12. Stages of drug
progression: a comparison of methods, concepts and operationalizations
Kazuo Yamaguchi; Part V. Animal Models and Biological Professes:
Implications for Drug Progression: 13. The value of animal models to
examine the gateway hypothesis Neil E. Grunberg and Martha M. Faraday; 14.
Sensitization as a process underlying the progression of drug use via
gateway drugs Susan Schenk; 15. The neurobiology of drug addiction George
Koob; Part VI. Conclusion: 16. The gateway hypothesis revisited Denise B.
Kandel and Richard Jessor.